Table 3.
Prevalence of study variables among the three adherence levels: oral and topical medication
| Characteristic | Oral medication (n = 1984) |
Topical medication (n = 2763) |
||||||
|---|---|---|---|---|---|---|---|---|
| High adherence n = 188 | Medium adherence n = 480 | Low adherence n = 1316 | P-value | High adherence n = 190 | Medium adherence n = 488 | Low adherence n = 2085 | P-value | |
| Age (years) mean ± SD | 47·28 ± 13·13 | 46·89 ± 12·27 | 43·75 ± 12·09 | < 0·001 | 48·01 ± 12·97 | 47·51 ± 13·76 | 45·57 ± 12·98 | 0·001 |
| Sex | ||||||||
| Male | 98 (10·7) | 239 (26·0) | 583 (63·4) | 0·030 | 105 (7·5) | 267 (19·0) | 1034 (73·5) | 0·057 |
| Female | 90 (8·5) | 241 (22·7) | 733 (68·9) | 85 (6·3) | 221 (16·3) | 1051 (77·5) | ||
| Marital status | ||||||||
| Married | 80 (10·0) | 194 (24·3) | 523 (65·6) | 0·757 | 67 (6·4) | 205 (19·5) | 780 (74·1) | 0·121 |
| Unmarried | 108 (9·1) | 286 (24·1) | 793 (66·8) | 123 (7·2) | 283 (16·5) | 1305 (76·3) | ||
| Annual income | ||||||||
| ≥ 6 million yena | 71 (10·6) | 170 (25·4) | 428 (64·0) | 0·469 | 70 (7·4) | 154 (16·2) | 724 (76·4) | 0·282 |
| < 6 million yen | 96 (9·3) | 250 (24·1) | 692 (66·7) | 98 (6·7) | 273 (18·7) | 1091 (74·6) | ||
| Employment | ||||||||
| Employed | 113 (8·8) | 314 (24·4) | 860 (66·8) | 0·306 | 122 (7·0) | 299 (17·1) | 1331 (76·0) | 0·624 |
| Unemployed | 65 (11·0) | 137 (23·1) | 391 (65·9) | 59 (6·7) | 163 (18·6) | 655 (74·7) | ||
| Education | ||||||||
| University graduate | 80 (8·4) | 237 (24·8) | 637 (66·8) | 0·264 | 84 (6·1) | 245 (17·8) | 1046 (76·1) | 0·283 |
| Not university graduate | 107 (10·5) | 241 (23·6) | 672 (65·9) | 105 (7·6) | 242 (17·6) | 1027 (74·8) | ||
| Smoking | ||||||||
| Smoker | 39 (9·9) | 90 (22·8) | 265 (67·3) | 0·760 | 32 (5·9) | 90 (16·6) | 421 (77·5) | 0·380 |
| Nonsmoker | 149 (9·4) | 389 (24·6) | 1044 (66·0) | 158 (7·2) | 398 (18·0) | 1653 (74·8) | ||
| Alcohol use | ||||||||
| More than once per month | 104 (8·6) | 277 (23·0) | 825 (68·4) | 0·033 | 112 (6·5) | 298 (17·2) | 1325 (76·4) | 0·244 |
| Less than once per month | 84 (10·9) | 202 (26·2) | 484 (62·9) | 78 (7·7) | 190 (18·7) | 749 (73·7) | ||
| Diseases | ||||||||
| Atopic dermatitis | 74 (8·1) | 181 (19·7) | 664 (72·3) | < 0·001 | 76 (5·9) | 223 (17·3) | 993 (76·9) | 0·080 |
| Urticaria | 62 (9·2) | 171 (25·4) | 440 (65·4) | 33 (6·3) | 97 (18·4) | 398 (75·4) | ||
| Psoriasis | 14 (12·5) | 36 (32·1) | 62 (55·4) | 12 (5·6) | 39 (18·1) | 165 (76·4) | ||
| Tinea | 38 (13·6) | 92 (32·9) | 150 (53·6) | 69 (9·5) | 129 (17·7) | 529 (72·8) | ||
| Frequency of hospital visits | ||||||||
| At least once per half year | 181 (9·9) | 431 (23·7) | 1210 (66·4) | 0·022 | 178 (7·2) | 445 (18·0) | 1846 (74·8) | 0·031 |
| Less than once per half year or unknown | 7 (4·3) | 49 (30·3) | 106 (65·4) | 12 (4·1) | 43 (14·6) | 239 (81·3) | ||
| Main healthcare institution | ||||||||
| University hospital | 13 (13·7) | 27 (28·4) | 55 (57·9) | 0·383 | 8 (6·6) | 17 (13·9) | 97 (79·5) | 0·336 |
| Municipal hospital | 34 (10·0) | 81 (23·9) | 224 (66·1) | 36 (7·3) | 101 (20·4) | 358 (72·3) | ||
| Private clinic or other | 138 (9·0) | 369 (24·0) | 1031 (67·0) | 145 (6·8) | 365 (17·1) | 1620 (76·1) | ||
| Experience of drug effectiveness | ||||||||
| Yes | 168 (10·3) | 416 (25·5) | 1050 (64·3) | < 0·001 | 175 (7·4) | 423 (17·9) | 1767 (74·7) | 0·016 |
| No | 20 (5·7) | 64 (18·3) | 266 (76·0) | 15 (3·8) | 65 (16·3) | 318 (79·9) | ||
| Experience of adverse events | ||||||||
| Yes | 28 (8·0) | 87 (24·9) | 234 (67·1) | 0·585 | 24 (6·3) | 65 (17·0) | 293 (76·7) | 0·810 |
| No | 160 (9·8) | 393 (24·0) | 1082 (66·2) | 166 (7·0) | 423 (17·8) | 1792 (75·3) | ||
| Overall satisfaction with treatment | ||||||||
| Satisfied | 115 (9·9) | 310 (26·6) | 740 (63·5) | 0·005 | 126 (7·9) | 291 (18·2) | 1180 (73·9) | 0·023 |
| Unsatisfied | 73 (8·9) | 170 (20·8) | 576 (70·3) | 64 (5·5) | 197 (16·9) | 905 (77·6) | ||
Values are n (% of row total) unless stated otherwise.
a
6 million yen is about £34 000 (at the time of writing).